Cyrenian House - Saranna Women and Children's

Cyrenian House - Saranna Women and Children's is a SAMHSA-registered addiction-treatment facility located at Bangor, ME. The facility offers specific levels of care: Inpatient. Patient-level evaluation of this facility should distinguish three considerations: state licensure status, voluntary accreditation (CARF or Joint Commission), and clinical-framework alignment with current ASAM Criteria — each of which is independently verifiable.

Care levels at Cyrenian House - Saranna Women and Children's

Level-of-care documentation: The facility's documented care levels are The facility offers specific levels of care: Inpatient. — each of which is appropriate for specific clinical presentations. Matching the level to the specific clinical need is the pre-admission work. Under MHPAEA 2024 medical-necessity criteria disclosure, plan-specific criteria for each of these levels must be available to patients upon request. Mismatch between documented clinical need and offered level of care is a common source of authorization denial.

Insurance and payment

Cyrenian House - Saranna Women and Children's accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The operational prerequisite for admission is written documentation of: (a) network contract status; (b) prior authorization; (c) cost-sharing structure; (d) medical-necessity criteria applied. Absence of any of these four increases the probability of post-admission financial disagreement.

Specialty programming

The facility's documented specialty programming includes: Young adults, Adult women, Pregnant/postpartum women. Evaluation of specialty-program alignment requires documented review of clinical team credentials, specialty-specific programming hours, and integrated assessment protocols. Specialty designation without documented clinical infrastructure is a recognized marketing pattern in the sector.

Before you call

Pre-admission due-diligence for Cyrenian House - Saranna Women and Children's: (1) ASAM 4e level-of-care documentation matching clinical assessment; (2) written Verification of Benefits specific to insurance product; (3) MAT policy documentation (particularly buprenorphine and methadone continuation protocols for opioid use disorder patients); (4) accreditation verification via CARF or Joint Commission provider-search tools; (5) state licensing status confirmed via ME behavioral-health regulator inspection records. If the clinical situation involves opioid use disorder, confirm explicitly whether Cyrenian House - Saranna Women and Children's offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.